Ohio sues five drugmakers over role in opioid crisis

May 31, 2017

The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public health.

The suit seeks to hold the companies accountable for harm to patients by blocking the drugs' allegedly deceptive marketing, as well as awarding compensation for the state and for consumers.

Prescription overdoses have hit record levels in the United States, killing more than 15,000 people in 2015 alone, according to the Centers for Disease Control and Prevention. West Virginia has also targeted drugmakers over the crisis.

In a statement, Ohio Attorney General Mike DeWine said the drugmakers had knowingly caused patients to become addicted, with many addicts then switching to heroin and other drugs.

"These drug manufacturers led prescribers to believe that opioids were not addictive, that addiction was an easy thing to overcome, or that addiction could actually be treated by taking even more opioids," DeWine said.

"They knew they were wrong but they did it anyway."

State officials say parts of Ohio are believed to be the hardest hit in the nation by the current opioid addiction crisis, with 2.3 million patients, or about 20 percent of the population, having been prescribed an last year.

The suit names Purdue Pharma, which markets drugs such as OxyContin and Dilaudid, Johnson & Johnson, Teva Pharmaceutical Industries, Endo Health Solutions and Allergan.

Explore further: Americans favor treatment, not enforcement, to address opioid crisis

Related Stories

Americans favor treatment, not enforcement, to address opioid crisis

May 23, 2017
Many Americans have been directly touched by the opioid crisis—more than a quarter of Americans and more than a third of millennials, report knowing someone who has been addicted to opioids or prescription painkillers. ...

US opioid crisis at epidemic proportions

May 4, 2017
Many US communities are facing an epidemic of opioid and heroin abuse that is straining resources from police, to jails, to emergency medical personnel and treatment centers.

US communities crumbling under an evolving addiction crisis

March 19, 2017
Of the 2,900 babies born last year in Cabell County, West Virginia, 500 had to be weaned off of opioid dependence.

Pfizer agrees to note addiction risks in opioid marketing

July 6, 2016
The city of Chicago and Pfizer announced an agreement Wednesday committing the drugmaker to disclosing the serious risks of addiction in its marketing of prescription opioid painkillers.

Utah launches campaign to fight opioid abuse, overdoses

April 30, 2017
Utah pharmacists will start putting red stickers on bottles of opioids that warn patients about the risk of overdose and addiction as part of a new awareness campaign to combat painkiller abuses and deaths.

CDC to launch awareness campaign warning of opioid dangers

April 19, 2017
The Centers for Disease Control and Prevention plans to launch a new ad campaign to raise awareness about the dangers of opioid addiction.

Recommended for you

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

Rapid response inpatient education boosts use of needed blood-thinning drugs

November 16, 2018
A new study designed to reach hospitalized patients at risk shows that a "real-time" educational conversation, video or leaflet can lower the missed dose rates of drugs that can prevent potentially lethal blood clots in their ...

Drug overdose epidemic goes far beyond opioids, requires new policies

November 7, 2018
Most government-funded initiatives to address the overdose epidemic in the United States have targeted opioids specifically and have neglected other drugs that are increasingly implicated in overdoses, such as cocaine and ...

Zebrafish larvae help in search for appetite suppressants

November 2, 2018
Researchers at the University of Zurich and Harvard University have developed a new strategy in the search for psychoactive drugs. By analyzing the behavior of larval zebrafish, they can filter out substances with unwanted ...

FDA OKs powerful opioid pill as alternative to IV painkiller

November 2, 2018
U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals.

Amphetamine-related hospitalizations surged between 2003 and 2015

November 2, 2018
An analysis conducted by Hennepin Healthcare, University of Minnesota School of Public Health and University of Michigan researchers shows amphetamine-related hospitalizations increased more than 270 percent from 2008 to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.